Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue increased primarily due to the weaker yen. Growth in existing core products and new products was offset by declines in products whose periods of exclusive distribution had expired and in mature products. Operating profit benefited from lower amortization of intangible assets, while research and development expenses and business restructuring costs increased. Profit attributable to owners of the parent declined due to higher income tax expense.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥1,219,900 million (YoY +10.2%) |
| Operating profit | ¥201,417 million (YoY +9.1%) |
| Ordinary income | ¥162,718 million (YoY +8.0%) |
| Profit attributable to owners of the parent | ¥113,197 million (YoY -8.9%) |
| Net income per share | ¥71.65 |
| Equity ratio | End of the current fiscal period 48.3 / End of previous period 47.9 |
| Total assets | ¥15,663,271 million |
| Net assets | ¥7,558,876 million |
| Cash flows from operating activities | ¥127,623 million |
| Cash flows from investing activities | ¥-87,703 million |
| Cash flows from financing activities | ¥-180,348 million |
| Cash and cash equivalents at end of period | ¥460,982 million |
| Full-year earnings forecast | Net Sales ¥4,640,000 million (YoY +3.0%) / Operating profit ¥420,000 million / Ordinary income ¥252,000 million / Net income ¥166,000 million |
| Annual Dividend Forecast | ¥200 → ¥204（+2.0%） |
| Regional sales | 1,039 Hundreds of millions of yen, 5,689 Hundreds of millions of yen, 2,821 Hundreds of millions of yen, 742 Hundreds of millions of yen, 523 Hundreds of millions of yen, 266 Hundreds of millions of yen, 354 Hundreds of millions of yen, 767 Hundreds of millions of yen |
| Depreciation and amortization | ¥163,042 million |
| Impairment loss | ¥5.4 billion in impairment losses on product-related intangible assets. Impairment losses reported in the statement of cash flows were ¥29,997 million, including a ¥3.1 billion increase in impairment losses on intangible assets following the discontinuation of development of the celiac disease development program. |
| Breakdown of extraordinary income (loss) | IFRS does not provide a separate extraordinary income or loss category. Non-recurring items comprised a ¥6.2 billion gain on the transfer of a business, ¥35.8 billion in business restructuring costs, and ¥5.4 billion in impairment losses on product-related intangible assets. |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (conference call held on 30 July; audience not specified) |
| Issued Shares at Period-End | 1,591,273,909 shares |
| Treasury Shares at Period-End | 10,976,853 shares |
| Factors Behind Changes in Business Performance | Revenue increased primarily due to the weaker yen. Growth in existing core products and new products was offset by declines in products whose periods of exclusive distribution had expired and in mature products. Operating profit benefited from lower amortization of intangible assets, while research and development expenses and business restructuring costs increased. Profit attributable to owners of the parent declined due to higher income tax expense. |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The increase in revenue was primarily attributable to the weaker yen. The decline in profit attributable to owners of the parent was due to higher income tax expense associated with a review of the recoverability of deferred tax assets, a decrease in tax credits, and additional tax liabilities under the U.S. international tax regime.